Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Canada
Tenecteplase

Health Canada 2026

Tenecteplase

Tnkase

25 MG / VIAL Powder For SolutionCanadaMarketedAuthorised 13 Aug 2026

Open in the registerAsk Osler about it

On this page

In other countries
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

TnkaseUnited States · 50MG/VIAL · vial · GenentechSame brand
TNKaseUnited States · 25MG · For Injection · Genentech, Inc.Same brand
MetalyseBrazil · Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda.Same substance
Metalyse 10.000 Unidades (50 MG) Polvo y Disolvente Para Solucion InyectableSpain · 1000 U · polvo y disolvente para solución inyectable · Boehringer Ingelheim International GmbhSame substance
Metalyse 5.000 Unidades (25 MG) Polvo Para Solucion InyectableSpain · 25 mg · polvo para solución inyectable · Boehringer Ingelheim International GmbhSame substance
Metalyse 8.000 Unidades (40 MG) Polvo y Disolvente Para Solucion InyectableSpain · 1000 U · polvo y disolvente para solución inyectable · Boehringer Ingelheim International Gmbh

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Same substance

🇪🇺MetalyseEuropean Union · Boehringer Ingelheim International GmbHSame substance

🇪🇺Tenecteplase Boehringer Ingelheim Pharma GmbH Co. KGEuropean Union · Boehringer Ingelheim International GmbHSame substance

🇭🇷MetalyseCroatiaSame substance

🇮🇹MetalyseItaly · Polvere e solvente per soluzione iniettabile · Boehringer Ingelheim International GMBHSame substance

🇳🇱Metalyse 10.000 units, poeder en oplosmiddel voor oplossing voor injectieNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Boehringer Ingelheim International GmbHSame substance

🇳🇱Metalyse 5.000 units, poeder voor oplossing voor injectieNetherlands · Poeder voor oplossing voor injectie · Boehringer Ingelheim International GmbHSame substance

🇳🇱Metalyse 8.000 units, poeder en oplosmiddel voor oplossing voor injectieNetherlands · Poeder en oplosmiddel voor oplossing voor injectie · Boehringer Ingelheim International GmbHSame substance

🇳🇿MetalyseNew Zealand · Inj 50 mg per vial with diluentSame substance

🇳🇿MetalyseNew Zealand · Inj 50 mg vial with diluentSame substance

🇷🇴Metalyse 10000 URomania · 5mg/ml (1000 U/ml · pulb. + solv. pt. sol. inj. · Boehringer Ingelheim International GMBHSame substance

🇷🇴Metalyse 8000 URomania · 5mg/ml (1000 U/ml · pulb. + solv. pt. sol. inj. · Boehringer Ingelheim International GMBHSame substance

🇷🇸Metalyse®Serbia · 5000jedinica · prašak za rastvor za injekciju · Boehringer Ingelheim Serbia D.O.O. BeogradSame substance

🇷🇸Metalyse®Serbia · 50mg/10mL · prašak i rastvarač za rastvor za injekciju · Boehringer Ingelheim Serbia D.O.O. BeogradSame substance

🇸🇦Metalyse 10000 U I.V VialSaudi Arabia · Boehringer IngelheimSame substance

🇸🇬METALYSE FOR INJECTION 10,000 u/vialSingapore · 10000 u/vial · injection, powder, for solution · Boehringer Ingelheim Singapore Pte. LTD.Same substance

🇸🇬METALYSE FOR INJECTION 5,000 u/vialSingapore · 5,000 units (25 mg)/vial · injection, powder, for solution · Boehringer Ingelheim Singapore Pte. LTD.Same substance

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tenecteplase
Strength: 25 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 13 Aug 2026
Registration: DIN 02562804
Marketing authorisation holder: Hoffmann-LA Roche Limited
ATC code: B01AD11
Group: Blood and blood-forming organs
Supply: PRESCRIPTION, SCHEDULE D